Studies of the Toxicological Potential of Capsinoids XIV: A 26-week Gavage Toxicity Study of Dihydrocapsiate in Rats

International Journal of Toxicology

Volumn 29, Issue 2_suppl, 2010, Pages 27S-54S

  Kodama, Terutaka ^a   Masuyama, Takeshi ^a   Kayahara, Takashi ^a   Tsubuku, Shoji ^a   Ohishi, Takumi ^b   Wagner, Bernard M ^c,d   Bernard, Bruce K ^e  

^a AJINOMOTO CO INC   (Japan)

^b Research Center Inc   (Japan)

^c NATIONAL ACADEMY OF SCIENCES   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e GENERAL DYNAMICS   (United States)

Author keywords

capsiate; capsinoids; chronic toxicity; dihydrocapsiate; rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CAPSAICIN DERIVATIVE; CHLORIDE; CHLORINE; CHOLESTEROL; CREATINE KINASE; CREATININE; DIHYDROCAPSIATE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; LACTATE DEHYDROGENASE; NITROGEN; PHOSPHATE; PHOSPHOLIPID; POTASSIUM; PROTEIN; SODIUM; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; UROBILINOGEN; CAPSAICIN; CAPSIATE; DRUG DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; BASOPHIL; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CALCIUM BLOOD LEVEL; CAPSICUM ANNUUM; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC TOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG SAFETY; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; EYE EXAMINATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROSCOPY; MONOCYTE; NEUTROPHIL COUNT; NO-OBSERVED-ADVERSE-EFFECT LEVEL; NONHUMAN; OCCULT BLOOD; ORGAN WEIGHT; OSMOLALITY; PARTIAL THROMBOPLASTIN TIME; PHOSPHATE BLOOD LEVEL; PHOSPHOLIPID BLOOD LEVEL; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTHROMBIN TIME; RAT; RETICULOCYTE; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; THROMBOCYTE COUNT; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE COLOR; URINE LEVEL; URINE SEDIMENT; URINE VOLUME; WEIGHT GAIN; ANIMAL; BLOOD; DOSE RESPONSE; DRINKING; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; ORGAN SIZE; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ANIMALS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; FEMALE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77955083572     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581809358925     Document Type: Article

References (26)

1. Yazawa S, Yoneda H, Hosokawa M, et al. Novel capsaicinoid like substances in the fruits of new non-pungent cultivar CH-19 sweet of pepper (Capsicum annuum). Capsicum and Eggplant Newsletter. 2004;23:17-20
2. Kobata K, Todo T, Yazawa S, et al. Novel capsaicinoid-like substances, capsiate and dihydrocapsiate, from the fruits of a nonpungent cultivar, CH-19 sweet, of pepper (Capsicum annuum L.). J Agric Food Chem. 1998;46:1696-1697
3. Kobata K, Sutoh K, Todo T, et al. Nordihydrocapsiate, a new capsinoids from the fruits of nonpungent pepper, Capsicum annuum. J Nat Prod. 1999;62:335-336
4. Kobata K, Kawaguchi M, Watanabe T. Enzymatic synthesis of a capsinoid by the acylation of vanillyl alcohol with fatty acid derivatives catalyzed by lipases. Biosci Biotechnol Biochem. 2002;66:319-327
5. Monsereenusorn Y. Subchronic toxicity studies of capsaicin and capsicum in rats. Res Commun Chem Pathol Pharmacol. 1983; 41:95-110
6. Akagi A, Sano N, Uehara H, et al. Non-carcinogenicity of capsaicinoids in B6C3F1 mice. Food Chem Toxicol. 1998;36: 1065-1067
7. Watanabe E, Kodama T, Masuyama T, Tsubuku S, Otabe A, Mochizuki M, Nakajima M, et al. Studies of the toxicological potential of capsinoids I: Single dose toxicity study and genotoxicity studies of CH-19 Sweet extract. Int J Toxicol. 2008;27(Suppl 3):1-9
8. Kodama T, Watanabe E, Masuyama T, Tsubuku S, Otabe A, Mochizuki M, et al. Studies of the toxicological potential of capsinoids: II. A 26-week daily gavage dosing toxicity study of CH-19 Sweet extract in rats. Int J Toxicol. 2008; 27(Suppl 3):11-27
9. Kodama T, Watanabe E, Masuyama T, Tsubuku S, Otabe A, Katsumata Y, et al. Studies of the toxicological potential of capsinoids III: A two-generation reproduction study of CH-19 Sweet extract in rats. Int J Toxicol. 2008;27(Suppl 3):29-39
10. Bernard BK, Watanabe E, Kodama T, Tsubuku S, Otabe A, Katsumata Y, et al. Studies of the toxicological potential of capsinoids IV: Teratology studies of CH-19 sweet extract in rats and rabbits. Int J Toxicol. 2008;27(Suppl 3):41-57
11. Bernard BK, Tsubuku S, Kayahara T, et al. Studies of the toxicological potential of capsinoids X: Safety assessment and pharmacokinetics of capsinoids in healthy male volunteers after a single oral ingestion of CH-19 sweet extract. Int J Toxicol. 2008; 27(Suppl 3):137-147
12. Bernard BK, Watanabe E, Kodama T, Tsubuku S, Otabe A, Nakajima M, et al. Studies of the toxicological potential of capsinoids V: Genotoxicity studies of dihydrocapsiate. Intl J Toxicol. 2008;27(S3):59-72
13. Watanabe E, Kodama T, Masuyama T, Tsubuku S, Nakajima M, et al. Studies of the toxicological potential of capsinoids VI: Single dose toxicity study and micronucleus test of commercial grade dihydrocapsiate. Int J Toxicol. 2008;27(Suppl 3):73-77
14. Kodama T, Watanabe E, Tsubuku S, et al. Studies of the toxicological potential of capsinoids: VII. A 13-week toxicity study of dihydrocapsiate in rats. Int J Toxicol. 2008;27(Suppl 3):79-99
15. Watanabe E, Kodama T, Masuyama T, Tsubuku S, Otabe A, Mochizuki M, Bernard BK. Studies of the toxicological potential of capsinoids VIII: A 13-week toxicity study of commercial grade dihydrocapsiate in rats. Intl J Toxicol. 2008;27(Suppl 3): 101-118
16. Bernard BK, Watanabe E, Kodama T, Tsubuku S, Otabe A, Ikeya M, et al. Studies of the toxicological potential of capsinoids IX: Teratology studies of dihydrocapsiate in rats and rabbits. Intl J Toxicol. 2008d;27(S3):119-136
17. Sokal RR, Rohlf FJ. Bartlett's test of homogeneity of variances. In: Biometry. San Francisco, CA: W. H. Freeman and Co. 1969: 370-371
18. Dunnett CW. New tables for multiple comparisons with a control. Biometrics. 1964;20:482-491
19. Steel RGD. A multiple comparison rank sum test: Treatments versus control. Biometrics. 1959;15:560-572
20. Fisher R. On the interpretation of w2 from contingency tables, and the calculation of P. J Royal Stat Soc. 1922;85:87-94
21. Krinke G, Naylor DC, Schmid S, et al. The incidence of naturally occurring primary brain tumors in the laboratory rat. J Comp Pathol. 1985;95:175-192
22. Maekawa A, Onodera H, Takigawa H, et al. Spontaneous tumors of the nervous system and associated organs and/or tissues in rats. Gann. 1984;75:784-791
23. Hard G, Johnson K, Cohen S. A comparison of rat chronic progressive nephropathy (CPN) with human renal disease: implications for human risk assessment. Crit Rev Toxicol. 2009;39:332-346
24. Bernard BK, Ubukata K, Mihara R, et al. Studies of the toxicological potential of capsinoids: XI. Pharmacokinetic and tissue distribution study of 14C-dihydrocapsiate (a capsinoid) and metabolites in rats. Int J Toxicol. 2010;29(suppl 1):3S-14S
25. Shirai Y, Ueno S, Nakayama A, et al. Studies of the toxicological potential of capsinoids XII: A pharmacokinetic study of capsinoidcontaining CH-19 sweet extract in rats. Int J Toxicol. 2010; 29(suppl 1):15S-21S
26. Takanohashi T, Isaka M, Ubukata K, et al. Studies of the toxicological potential of capsinoids XIII: Inhibitory effects of capsiaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010;29(suppl 1):22S-26S.